EVH Earnings & Financial Statements
Evolent Health, Inc.
$4.04
+$0.08(+2.02%)
56
Overall
60
Value
63
Tech
47
Quality
Market Cap
$447.71M
Volume
1.07M
52W Range
$2.10 - $8.46
Target Price
$5.77
EVH earnings and financial statements: Evolent Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
EVH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $907.96M |
| Cost of revenue | $1.48B | $2.19B | $1.50B | $1.04B | $657.55M |
| Operating income | -$410.14M | -$40.48M | -$71.21M | $3.64M | -$42.41M |
| EBITDA | -$353.48M | $83.62M | -$21.01M | $22.99M | $49.11M |
| Net income | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -$37.60M |
| EPS (diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B |
| Total liabilities | $1.48B | $1.35B | $1.43B | $957.88M | $725.83M |
| Shareholders’ equity | $415.19M | $1.00B | $1.07B | $859.42M | $693.63M |
| Cash and equivalents | $151.86M | $104.20M | $192.82M | $188.20M | $266.28M |
| Long-term debt | $974.36M | $515.49M | $635.06M | $469.00M | $273.40M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $38.84M | $18.77M | $142.58M | -$11.55M | $38.75M |
| Capital expenditure | -$34.09M | -$24.89M | -$28.75M | -$38.36M | -$24.98M |
| Free cash flow | $4.75M | -$6.13M | $113.84M | -$49.91M | $13.76M |
| Dividends paid | $11.13M | $20.09M | $18.79M | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EVH | $4.04 | +2.0% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |